On October 17, Aehr Test fell 8.27% in Regular Trading, trading near $63.5, with turnover of $93.03 million.
The move was tied to continued market repricing after Teradyne introduced Titan HP, which has raised concerns about competitive pressure on Aehr Test in semiconductor test and burn-in equipment.
Recent market reports said selling pressure intensified as investors reassessed the potential impact of the new Teradyne product. At the same time, some institutional views described the share-price reaction as potentially overdone, noting Aehr Test has recently secured a $22 million follow-on order for wafer-level AI processor capacity, about $6 million in additional AI chip test equipment orders, and ongoing expansion orders from silicon photonics customers, indicating demand in AI test and burn-in equipment is still developing.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments